LIVZON PHARMA (01513) plans to distribute a special interim dividend of 10.20 yuan for every 10 shares.
Lizu Pharmaceutical (01513) announced that in the first half of 2026, the company maintained a good operational performance and profit level. The cumulative undistributed profits are high, monetary funds are sufficient, and the asset-liability structure is stable. The existing funds can cover research and development investments as well as daily operational needs. To reward all shareholders for their long-standing trust and support for the company, the board of directors has resolved to declare a special interim dividend of RMB 10.20 per 10 shares (tax included), totaling approximately RMB 906 million (tax included) in special interim dividends.
LIVZON PHARMA (01513) announced that in the first half of 2026, the company maintained good operational conditions and profit levels. The company has accumulated a high amount of undistributed profits, sufficient cash reserves, and a stable asset-liability structure. The existing funds can cover research and development investments as well as daily operational needs. In order to reward all shareholders for their long-standing trust and support for the company, the board of directors has resolved to distribute a special interim dividend of RMB 10.20 (including tax) for every 10 shares, with a total proposed special interim dividend of approximately RMB 906 million (including tax).
Related Articles
SPRING REIT (01426) spent approximately HKD 134,400 to repurchase 109,000 shares on September 8.
Bairong AI-W (06608) spent HKD 77,200 to repurchase 15,500 shares on September 8.
CHINA SOUTH AIR (01055) has applied for approval from the China Securities Regulatory Commission for the registration of A-share stock issuance to specific targets.
SPRING REIT (01426) spent approximately HKD 134,400 to repurchase 109,000 shares on September 8.
Bairong AI-W (06608) spent HKD 77,200 to repurchase 15,500 shares on September 8.
CHINA SOUTH AIR (01055) has applied for approval from the China Securities Regulatory Commission for the registration of A-share stock issuance to specific targets.
RECOMMEND
